A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19Bin Cao, Chunmin Jia, Lianguo Ruan et al.|New England Journal of Medicine|2020Cited by 5.5k
Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): A single-center, open-label, randomized controlled trialJia Liu, Luqi Huang, Wei Yang et al.|Phytomedicine|2021Cited by 71
Double-Dose Dolutegravir and Lamivudine Versus Efavirenz-Based Antiretroviral Therapy for Patients Coinfected with HIV and Tuberculosis: A Multicentre Open-Label, Randomised TrialXiaoqin Le, Yinzhong Shen, Wei Song et al.|EMJ Microbiology & Infectious Diseases|2025Cited by 0